We believe that DexCom, best known for its continuous glucose monitoring systems, currently is an attractive pick over Amedisys stock (NASDAQ: AMED), a home health and hospice company with a similar r

DexCom (DXCM) to Boost Diabetes Management With New Approval

12:03pm, Tuesday, 15'th Mar 2022

DexCom's (DXCM) G7 CGM System receives CE Mark that can help people with diabetes in Europe, including pregnant women.

Dexcom Snags A New Diabetes Device Win After Covid-Related Delay

05:22pm, Monday, 14'th Mar 2022 Investor''s Business Daily

European officials approved Dexcom''s newest body-worn diabetes device on Monday, leading Dexcom stock to surge closer to its 50-day line.

Dexcom G7 Continuous Glucose Monitoring System Receives European CE Mark

01:33pm, Monday, 14'th Mar 2022 Benzinga

DexCom Inc''s (NASDAQ: DXCM ) Dexcom G7 Continuous Glucose Monitoring (CGM) System has secured European CE Mark for people with diabetes aged two years and older, including pregnant women. The Company adds that the Dexcom G7 all-in-one wearable warms with 30-minute sensor warm-up is faster than … Full story available on Benzinga.com

Dexcom (DXCM) G6 CGM System Gets Public Coverage From Ontario

12:02pm, Monday, 14'th Mar 2022

Dexcom's (DXCM) G6 CGM System can help people with type 1 diabetes over two years of age through the coverage announced by the Ontario government.

Dexcom glucose monitoring system for managing diabetes gets CE Mark in Europe

08:52am, Monday, 14'th Mar 2022 Seeking Alpha

DexCom (DXCM) said it secured CE Mark (Conformité Européenne) for the Dexcom G7 Continuous Glucose Monitoring ((CGM)) system for people with diabetes in Europe age two years and…

Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management

07:30am, Monday, 14'th Mar 2022 Business Wire

EDINBURGH, Scotland & SAN DIEGO--(BUSINESS WIRE)---- $DXCM #CGM--Dexcom G7 Receives CE Mark – Next Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management